glp-1 agonist side effects Adverse of class drugs. Gastrointestinal issues are Full article: Managing the gastrointestinal
Description
95% CI, 0.29-0.96) and meningioma (HR = 0.69
Diabetes 58, 22582266
In the absence of such a marker, there is value to understand what (if any) clinical factors are associated with increased risk of PDAC amongst those who are using GLP-1RAs
Mixed comparison pooled estimates were generated using MetaXL software [25]
At 12mg, over 80% of participants lost 15% or more of their body weight
